These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3630637)

  • 21. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
    Tzartos SJ
    In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-receptor striated muscle antibodies in sera from patients with myasthenia gravis.
    Aarli JA; Flood PR; Gilhus NE; Hofstad H; Matre R
    Monogr Allergy; 1988; 25():128-34. PubMed ID: 2971876
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autoantibodies in Myasthenia Gravis].
    Higuchi O
    Brain Nerve; 2018 Apr; 70(4):419-426. PubMed ID: 29632289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants.
    Bartoccioni E; Evoli A; Casali C; Scoppetta C; Tonali P; Provenzano C
    J Neuroimmunol; 1986 Aug; 12(2):155-61. PubMed ID: 3734055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
    Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
    Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of block of nicotinic acetylcholine receptor channels by purified IgG from seropositive patients with myasthenia gravis.
    Jahn K; Franke C; Bufler J
    Neurology; 2000 Jan; 54(2):474-9. PubMed ID: 10668717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific adsorbents for myasthenia gravis autoantibodies using mutants of the muscle nicotinic acetylcholine receptor extracellular domains.
    Lazaridis K; Evaggelakou P; Bentenidi E; Sideri A; Grapsa E; Tzartos SJ
    J Neuroimmunol; 2015 Jan; 278():19-25. PubMed ID: 25595248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of antibodies to neuronal α7-acetylcholine receptors in myasthenia.
    Lantzova VB; Sepp EK; Kozlovskii AS
    Bull Exp Biol Med; 2011 Jul; 151(3):305-7. PubMed ID: 22451872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of quantitative antibodies measurement in blood serum by interaction with muscle acetylcholine receptor domain in myasthenia patients].
    Gekht BM; Lantsova VB; Sepp EK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(2):34-7. PubMed ID: 12674702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay of antibodies to acetylcholine receptor in serum of myasthenia gravis patients.
    Brenner T; Abramsky O; Lisak RP; Zweiman B; Tarrab-Hazdai R; Fuchs S
    Isr J Med Sci; 1978 Sep; 14(9):986-9. PubMed ID: 721428
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental autoimmune myasthenia gravis in the mouse.
    Wu B; Goluszko E; Huda R; Tüzün E; Christadoss P
    Curr Protoc Immunol; 2011 Nov; Chapter 15():Unit 15.23. PubMed ID: 22048803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of foetal and adult human acetylcholine receptors with serum from patients with myasthenia gravis.
    Lotwick H; Harrison R; Lunt G; Behan P
    J Neuroimmunol; 1983 Jun; 4(3):167-74. PubMed ID: 6853696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia gravis: results of serological investigations compared with clinical data.
    Aarli JA
    Acta Neurol Scand; 1971; 47(5):594-602. PubMed ID: 5139724
    [No Abstract]   [Full Text] [Related]  

  • 39. Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels.
    Bufler J; Pitz R; Czep M; Wick M; Franke C
    Ann Neurol; 1998 Apr; 43(4):458-64. PubMed ID: 9546326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to skeletal muscle in myasthenia gravis. Part 3. Relation with clinical course and therapy.
    Kuks JB; Limburg PC; Horst G; Oosterhuis HJ
    J Neurol Sci; 1993 Dec; 120(2):168-73. PubMed ID: 8138806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.